Found 490 results in Expert Content

Summary: In this article, experts discuss how the intranasal route offers advantages like faster absorption and minimal product degradation, but also the complex issues to consider when designing a device that will ensure the efficacy of a particular formulation.

Summary: Zydis® orally disintegrating tablet (ODT) technology creates a unique, freeze-dried oral solid dosage form that disperses almost instantly in the mouth, without water. With more than 35 products launched in 60+ countries, Zydis is the world’s fastest and best-in-class ODT.

Summary: Comprehensive toolkit that offers a developability assessment specific to protein degraders.

Summary: This article, originally published in Inhalation Magazine, discusses process & applications considerations for the spray drying of inhaled powders, considerations for formulating biologics as respirable powders and inhalation for non-respiratory indications.

During the webinar, viewers will gain valuable insights through a series of case studies demonstrating how mathematical and computerized models were utilized to improve scale-up and efficiency in oral solid dose manufacturing.

Summary: Watch this webinar to explore risk-based approaches to reduce the burden of analytical testing without compromising patient safety.

Summary: During this webinar, experts present the principles, mechanisms and several downstream applications of patented twin-screw granulation technique for oral solid dosage forms.

Summary: During this webinar, experts present the principles, mechanisms and several downstream applications of patented twin-screw granulation technique for oral solid dosage forms.

Summary: In this webinar, speakers will share industry insights into small molecule drug development advancements and discuss innovative, scalable drug delivery technologies proven to address the industry’s growing need for improving solubility and enhancing bioavailability.

Summary: In this webinar, experts discuss the key drivers and challenges of orphan drug development and manufacturing.